| Serial Number | 97388155 |
| Word Mark | DEJOURA |
| Filing Date | Friday, April 29, 2022 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Wednesday, October 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 21, 2023 |
| Goods and Services | Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders (skin), musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 4, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Party Name | TEVA PHARMACEUTICALS USA, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Parsippany, NJ 07054 |
| Event Date | Event Description |
| Thursday, July 7, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, May 3, 2022 | NEW APPLICATION ENTERED |
| Wednesday, May 4, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 7, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, July 7, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, February 2, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, February 2, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, February 2, 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Thursday, February 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 15, 2023 | ASSIGNED TO EXAMINER |
| Thursday, February 16, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 21, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 16, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, November 9, 2023 | SOU TEAS EXTENSION RECEIVED |
| Thursday, November 9, 2023 | SOU EXTENSION 1 FILED |
| Thursday, November 9, 2023 | SOU EXTENSION 1 GRANTED |
| Saturday, November 11, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 26, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, April 26, 2024 | SOU EXTENSION 2 FILED |
| Friday, April 26, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 30, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, October 30, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, October 30, 2024 | SOU EXTENSION 3 FILED |
| Wednesday, October 30, 2024 | SOU EXTENSION 3 GRANTED |
| Saturday, April 27, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |